GSP Crop Science Announces IPO Price Band Ahead of March 16

Agrochemical manufacturer GSP Crop Science has revealed the price band for its upcoming initial public offering, marking its entry into India’s public equity market. The company plans to raise significant capital through a combination of fresh equity issuance and an offer for sale by existing shareholders. The IPO is scheduled to open for subscription on March 16 and will be listed on India’s major stock exchanges.

GSP Crop Science Sets IPO Price Band for Public Issue

Agrochemical Firm Targets ₹400 Crore Fundraising

Agrochemical company GSP Crop Science has announced the price band for its highly anticipated initial public offering (IPO), which will open for subscription on March 16. The company has fixed the price band between ₹304 and ₹320 per equity share as it prepares to enter India’s capital markets.

At the upper end of the price band, the company aims to raise approximately ₹400 crore from investors. The IPO will consist of a mix of a fresh issue of equity shares and an offer for sale (OFS) by existing shareholders.

Investors interested in the offering will be required to bid for a minimum lot size of 46 shares, with the option to apply for additional shares in multiples of the same lot.

The IPO will remain open for subscription from March 16 to March 18. Prior to the public offering, the company plans to allocate shares to anchor investors on March 13.

Following the listing, the company is expected to achieve a market capitalisation of around ₹1,488.6 crore at the upper price band.

Structure of the IPO Issue

Fresh Issue and Offer for Sale Components

The total issue size of the IPO is estimated at ₹400 crore. Out of this, ₹240 crore will be raised through a fresh issue of shares, while the remaining portion will come through an offer for sale of 50 lakh equity shares by existing promoters and stakeholders.

The OFS will see promoters and related shareholders partially divesting their stakes. The selling shareholders include Vilasben Vrajmohan Shah, Bhavesh Vrajmohan Shah, and Kappa Trust.

Funds raised from the fresh issue will be utilised primarily to reduce the company’s existing debt obligations and support general corporate purposes. Meanwhile, proceeds from the OFS will go directly to the selling shareholders rather than the company.

The issue has been structured to attract participation from different categories of investors. As per regulatory guidelines, 50 percent of the issue has been reserved for qualified institutional buyers (QIBs), while 15 percent has been allocated to non institutional investors (NIIs). The remaining 35 percent will be available for retail investors.

Timeline of the IPO Process

Regulatory Approval and Subscription Schedule

GSP Crop Science had originally filed its draft red herring prospectus (DRHP) with the market regulator in November 2024. The proposal received approval from the Securities and Exchange Board of India in the final week of March 2025.

Under Indian regulatory norms, companies must launch their IPO within one year after receiving the regulator’s observations. As the approval period was set to expire soon, the company has now moved forward with the public offering.

The IPO subscription window will remain open for three days, from March 16 to March 18. The allocation of shares to investors is expected to be finalised on March 20.

The company’s shares are scheduled to be listed on both the Bombay Stock Exchange and the National Stock Exchange of India on March 24.

Revision in Issue Size from Draft Prospectus

Company Reduces Fresh Issue and OFS Components

Compared to the details disclosed earlier in the draft prospectus, the company has revised the size of both the fresh issue and the offer for sale.

The fresh issue has been reduced from ₹280 crore to ₹240 crore, while the OFS portion has been scaled down from 60 lakh shares to 50 lakh shares.

These adjustments are not uncommon during the IPO preparation process, as companies often refine their capital requirements and ownership structures before launching a public issue.

Business Overview of GSP Crop Science

Agrochemical Manufacturing and Innovation

GSP Crop Science operates in the agrochemical sector and is engaged in the manufacturing of various crop protection and agricultural productivity products.

The company’s product portfolio includes insecticides, herbicides, fungicides, and plant growth regulators. These products play a critical role in improving crop yields and protecting agricultural output from pests and diseases.

The company has also invested heavily in research and development to expand its product offerings. As of September 2025, the company had secured 524 product registrations across agrochemical formulations and technical products.

In addition, it has been granted 102 patents and currently has 108 patent applications under review.

This strong intellectual property pipeline highlights the company’s focus on innovation and technological development within the agrochemical industry.

Financial Performance and Growth

Strong Profit Growth in Recent Years

Financially, GSP Crop Science has reported consistent growth over the past few years.

For the financial year ending FY25, the company recorded a profit of ₹83.4 crore. This represents a significant increase of approximately 36 percent compared with ₹61.3 crore in the previous financial year.

Revenue also witnessed steady expansion during the same period. The company’s total revenue rose to ₹1,287.4 crore in FY25, reflecting an 11.7 percent growth from ₹1,152.2 crore in the prior year.

The company has also demonstrated strong performance in the first half of the current financial year. For the six month period ending September 2025, it reported a profit of ₹82.7 crore on revenue of ₹844.2 crore.

However, the company continues to carry a substantial debt burden. As of December 2025, its total outstanding borrowings stood at ₹478.8 crore, including ₹282.7 crore of fund based borrowings.

A portion of the funds raised from the IPO will therefore be used to reduce debt and strengthen the company’s balance sheet.

Competitive Landscape in the Agrochemical Sector

Competition from Established Industry Players

The Indian agrochemical industry is highly competitive, with several well established companies operating in the sector.

GSP Crop Science competes with a range of listed peers including PI Industries, Sumitomo Chemical, Dhanuka Agritech, Rallis India, Bharat Rasayan, India Pesticides, Excel Industries, and Heranba Industries.

These companies operate across various segments of crop protection chemicals and agricultural solutions.

Despite strong competition, industry analysts note that India’s agrochemical sector continues to expand due to rising agricultural demand, increasing crop protection needs, and growing exports of agrochemical products.

IPO Management and Advisors

Lead Managers and Registrar

The IPO is being managed by leading investment banks acting as book running lead managers. These include Equirus Capital and Motilal Oswal Investment Advisors.

The registrar to the issue has been appointed as MUFG Intime India.

These firms will oversee the subscription process, share allocation, and regulatory compliance throughout the IPO process.

Outlook for the Company

The IPO marks an important milestone for GSP Crop Science as it seeks to expand its operations and strengthen its financial position.

By reducing debt and raising capital through the stock market, the company aims to improve its balance sheet and invest in future growth opportunities.

With agriculture remaining a vital sector in India’s economy and demand for crop protection solutions continuing to rise, the company may benefit from increasing market opportunities in the coming years.